Premium
Effect of an increased clopidogrel maintenance dose or lansoprazole co‐administration on the antiplatelet response to clopidogrel in CYP2C19‐genotyped healthy subjects
Author(s) -
HULOT J.S.,
WUERZNER G.,
BACHELOTLOZA C.,
AZIZI M.,
BLANCHARD A.,
PEYRARD S.,
FUNCKBRENTANO C.,
GAUSSEM P.
Publication year - 2010
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2009.03729.x
Subject(s) - clopidogrel , lansoprazole , cyp2c19 , medicine , ticlopidine , antiplatelet drug , cardiology , aspirin , pharmacology , omeprazole , cytochrome p450 , metabolism